
The global market for Cell Line Authentication Services was valued at US$ 818 million in the year 2024 and is projected to reach a revised size of US$ 1199 million by 2031, growing at a CAGR of 5.7% during the forecast period.
Cell line authentication services are essential for confirming the identity and purity of cell lines used in research, clinical, and industrial applications. Authentication ensures that the cell lines have not been cross-contaminated or misidentified, which is crucial for maintaining the integrity and reproducibility of experimental results.
North American market for Cell Line Authentication Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cell Line Authentication Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Cell Line Authentication Services in Human Cell Line is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Cell Line Authentication Services include Applied Biological Materials Inc. (abm), ATCC, Microsynth, Eurofins, Generi Biotech, Promega, NorthGene, Labcorp, DSMZ, Biofortuna, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cell Line Authentication Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Line Authentication Services.
The Cell Line Authentication Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cell Line Authentication Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell Line Authentication Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Applied Biological Materials Inc. (abm)
ATCC
Microsynth
Eurofins
Generi Biotech
Promega
NorthGene
Labcorp
DSMZ
Biofortuna
1st BASE
Multiplexion
IDEXX BioAnalytics
Segment by Type
Short Tandem Repeat (STR) Profiling
Single Nucleotide Polymorphism (SNP) Genotyping
Others
Segment by Application
Human Cell Line
Mouse Cell Line
Stem Cell Line
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell Line Authentication Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Cell Line Authentication Services 麻豆原创 Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Short Tandem Repeat (STR) Profiling
1.2.3 Single Nucleotide Polymorphism (SNP) Genotyping
1.2.4 Others
1.3 麻豆原创 by Application
1.3.1 Global Cell Line Authentication Services 麻豆原创 Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Human Cell Line
1.3.3 Mouse Cell Line
1.3.4 Stem Cell Line
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell Line Authentication Services 麻豆原创 Perspective (2020-2031)
2.2 Global Cell Line Authentication Services Growth Trends by Region
2.2.1 Global Cell Line Authentication Services 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cell Line Authentication Services Historic 麻豆原创 Size by Region (2020-2025)
2.2.3 Cell Line Authentication Services Forecasted 麻豆原创 Size by Region (2026-2031)
2.3 Cell Line Authentication Services 麻豆原创 Dynamics
2.3.1 Cell Line Authentication Services Industry Trends
2.3.2 Cell Line Authentication Services 麻豆原创 Drivers
2.3.3 Cell Line Authentication Services 麻豆原创 Challenges
2.3.4 Cell Line Authentication Services 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Line Authentication Services Players by Revenue
3.1.1 Global Top Cell Line Authentication Services Players by Revenue (2020-2025)
3.1.2 Global Cell Line Authentication Services Revenue 麻豆原创 Share by Players (2020-2025)
3.2 Global Top Cell Line Authentication Services Players by Company Type and 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cell Line Authentication Services Revenue
3.4 Global Cell Line Authentication Services 麻豆原创 Concentration Ratio
3.4.1 Global Cell Line Authentication Services 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Line Authentication Services Revenue in 2024
3.5 Global Key Players of Cell Line Authentication Services Head office and Area Served
3.6 Global Key Players of Cell Line Authentication Services, Product and Application
3.7 Global Key Players of Cell Line Authentication Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Line Authentication Services Breakdown Data by Type
4.1 Global Cell Line Authentication Services Historic 麻豆原创 Size by Type (2020-2025)
4.2 Global Cell Line Authentication Services Forecasted 麻豆原创 Size by Type (2026-2031)
5 Cell Line Authentication Services Breakdown Data by Application
5.1 Global Cell Line Authentication Services Historic 麻豆原创 Size by Application (2020-2025)
5.2 Global Cell Line Authentication Services Forecasted 麻豆原创 Size by Application (2026-2031)
6 North America
6.1 North America Cell Line Authentication Services 麻豆原创 Size (2020-2031)
6.2 North America Cell Line Authentication Services 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cell Line Authentication Services 麻豆原创 Size by Country (2020-2025)
6.4 North America Cell Line Authentication Services 麻豆原创 Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell Line Authentication Services 麻豆原创 Size (2020-2031)
7.2 Europe Cell Line Authentication Services 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cell Line Authentication Services 麻豆原创 Size by Country (2020-2025)
7.4 Europe Cell Line Authentication Services 麻豆原创 Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell Line Authentication Services 麻豆原创 Size (2020-2031)
8.2 Asia-Pacific Cell Line Authentication Services 麻豆原创 Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cell Line Authentication Services 麻豆原创 Size by Region (2020-2025)
8.4 Asia-Pacific Cell Line Authentication Services 麻豆原创 Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell Line Authentication Services 麻豆原创 Size (2020-2031)
9.2 Latin America Cell Line Authentication Services 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cell Line Authentication Services 麻豆原创 Size by Country (2020-2025)
9.4 Latin America Cell Line Authentication Services 麻豆原创 Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Line Authentication Services 麻豆原创 Size (2020-2031)
10.2 Middle East & Africa Cell Line Authentication Services 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cell Line Authentication Services 麻豆原创 Size by Country (2020-2025)
10.4 Middle East & Africa Cell Line Authentication Services 麻豆原创 Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Applied Biological Materials Inc. (abm)
11.1.1 Applied Biological Materials Inc. (abm) Company Details
11.1.2 Applied Biological Materials Inc. (abm) Business Overview
11.1.3 Applied Biological Materials Inc. (abm) Cell Line Authentication Services Introduction
11.1.4 Applied Biological Materials Inc. (abm) Revenue in Cell Line Authentication Services Business (2020-2025)
11.1.5 Applied Biological Materials Inc. (abm) Recent Development
11.2 ATCC
11.2.1 ATCC Company Details
11.2.2 ATCC Business Overview
11.2.3 ATCC Cell Line Authentication Services Introduction
11.2.4 ATCC Revenue in Cell Line Authentication Services Business (2020-2025)
11.2.5 ATCC Recent Development
11.3 Microsynth
11.3.1 Microsynth Company Details
11.3.2 Microsynth Business Overview
11.3.3 Microsynth Cell Line Authentication Services Introduction
11.3.4 Microsynth Revenue in Cell Line Authentication Services Business (2020-2025)
11.3.5 Microsynth Recent Development
11.4 Eurofins
11.4.1 Eurofins Company Details
11.4.2 Eurofins Business Overview
11.4.3 Eurofins Cell Line Authentication Services Introduction
11.4.4 Eurofins Revenue in Cell Line Authentication Services Business (2020-2025)
11.4.5 Eurofins Recent Development
11.5 Generi Biotech
11.5.1 Generi Biotech Company Details
11.5.2 Generi Biotech Business Overview
11.5.3 Generi Biotech Cell Line Authentication Services Introduction
11.5.4 Generi Biotech Revenue in Cell Line Authentication Services Business (2020-2025)
11.5.5 Generi Biotech Recent Development
11.6 Promega
11.6.1 Promega Company Details
11.6.2 Promega Business Overview
11.6.3 Promega Cell Line Authentication Services Introduction
11.6.4 Promega Revenue in Cell Line Authentication Services Business (2020-2025)
11.6.5 Promega Recent Development
11.7 NorthGene
11.7.1 NorthGene Company Details
11.7.2 NorthGene Business Overview
11.7.3 NorthGene Cell Line Authentication Services Introduction
11.7.4 NorthGene Revenue in Cell Line Authentication Services Business (2020-2025)
11.7.5 NorthGene Recent Development
11.8 Labcorp
11.8.1 Labcorp Company Details
11.8.2 Labcorp Business Overview
11.8.3 Labcorp Cell Line Authentication Services Introduction
11.8.4 Labcorp Revenue in Cell Line Authentication Services Business (2020-2025)
11.8.5 Labcorp Recent Development
11.9 DSMZ
11.9.1 DSMZ Company Details
11.9.2 DSMZ Business Overview
11.9.3 DSMZ Cell Line Authentication Services Introduction
11.9.4 DSMZ Revenue in Cell Line Authentication Services Business (2020-2025)
11.9.5 DSMZ Recent Development
11.10 Biofortuna
11.10.1 Biofortuna Company Details
11.10.2 Biofortuna Business Overview
11.10.3 Biofortuna Cell Line Authentication Services Introduction
11.10.4 Biofortuna Revenue in Cell Line Authentication Services Business (2020-2025)
11.10.5 Biofortuna Recent Development
11.11 1st BASE
11.11.1 1st BASE Company Details
11.11.2 1st BASE Business Overview
11.11.3 1st BASE Cell Line Authentication Services Introduction
11.11.4 1st BASE Revenue in Cell Line Authentication Services Business (2020-2025)
11.11.5 1st BASE Recent Development
11.12 Multiplexion
11.12.1 Multiplexion Company Details
11.12.2 Multiplexion Business Overview
11.12.3 Multiplexion Cell Line Authentication Services Introduction
11.12.4 Multiplexion Revenue in Cell Line Authentication Services Business (2020-2025)
11.12.5 Multiplexion Recent Development
11.13 IDEXX BioAnalytics
11.13.1 IDEXX BioAnalytics Company Details
11.13.2 IDEXX BioAnalytics Business Overview
11.13.3 IDEXX BioAnalytics Cell Line Authentication Services Introduction
11.13.4 IDEXX BioAnalytics Revenue in Cell Line Authentication Services Business (2020-2025)
11.13.5 IDEXX BioAnalytics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Applied Biological Materials Inc. (abm)
ATCC
Microsynth
Eurofins
Generi Biotech
Promega
NorthGene
Labcorp
DSMZ
Biofortuna
1st BASE
Multiplexion
IDEXX BioAnalytics
听
听
*If Applicable.
